Natural History of Autosomal Dominant Hearing Loss
Recruiting
Observational Study
Hearing Loss
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
Healthy Volunteers Welcome
You do not need to have the condition being studied to take part.
No Study Drug
Researchers observe your health over time — no experimental treatment is given.
Ready to participate?
Review the details below, then apply to join this clinical trial.
At a Glance
Age
3 – 99
Sex
Any
Study type
Observational
Participants needed
1,100 (estimated)
Sponsor
National Institute on Deafness and Other Communication Disorders (NIDCD) · NIH
Who this trial is looking for
This trial is looking for people aged 3 to 99 with hereditary hearing loss and their family members. Participants will have hearing tests, balance tests, and some may provide blood or skin samples for gene testing.
Are You a Good Fit for This Trial?
You may be able to join if
I have hereditary hearing loss confirmed by genetic testing
I am a family member of someone with hereditary hearing loss
I am a healthy family member of an enrolled participant
I can provide informed consent or have a parent/guardian who can
I am between 3 and 99 years old
You may not be able to join if
I have hearing loss from an infection or illness
I have hearing loss due to medication like cisplatin
I have hearing loss from surgery like acoustic neuroma removal
I cannot provide informed consent due to cognitive impairment
Summarized in plain language from this trial's official eligibility criteria.
The full criteria are further down this page — only the research team can
confirm whether you qualify.
Think this trial could be right for you?
Answer three quick questions written from this study's own rules to see if you may qualify. No account needed to find out.
Background:
Hereditary hearing loss is one of the most common sensory disabilities affecting newborns. The main options for people with hereditary hearing loss are hearing aids and cochlear implants. Both options have their limitations and do not restore biological hearing. Researchers want to learn if gene editing might be a treatment option.
Objective:
To understand the genes that cause non-s…
Background:
Hereditary hearing loss is one of the most common sensory disabilities affecting newborns. The main options for people with hereditary hearing loss are hearing aids and cochlear implants. Both options have their limitations and do not restore biological hearing. Researchers want to learn if gene editing might be a treatment option.
Objective:
To understand the genes that cause non-syndromic autosomal dominant hearing loss (DFNA) in people with DFNA as well as their family members.
Eligibility:
People age 3 99 who have DFNA, affected family members of enrolled participants with DFNA, and unaffected family members of enrolled participants
Design:
Participants will be screened with a medical and hearing history. Their medical records will be reviewed.
Participants will have hearing tests. They will wear headphones or earplugs. They will listen to tones, sounds, and words and may be asked to describe what they hear.
Participants will have balance tests. For these, they will wear googles as they watch moving lights or as cold or warm air is blown into their ears. They will sit in a spinning chair in a quiet, dark booth. From a reclined position, they will raise their head while listening to clicking sounds.
Participants will have blood drawn through a needle in the arm. Some blood will be used for gene testing.
Some participants will have 2 skin biopsies. The skin will be washed, and a numbing medicine will be injected. Two small pieces of skin will be removed.
Participants may have a physical exam.
Participation will last for up to 20 years. Participants may give medical updates once a year.
Trial Locations
Loading…
Loading trial locations…
Facility
City
State
Country
Status
Eligibility Criteria
* INCLUSION CRITERIA:
* Affected persons with autosomal dominant hereditary sensorineural hearing loss, preferably confirmed by prior genetic testing
* Affected family members of enrolled participants with known autosomal dominant hereditary hearing loss
* Unaffected Family Members (Healthy Voluntee…
* INCLUSION CRITERIA:
* Affected persons with autosomal dominant hereditary sensorineural hearing loss, preferably confirmed by prior genetic testing
* Affected family members of enrolled participants with known autosomal dominant hereditary hearing loss
* Unaffected Family Members (Healthy Volunteers) of enrolled participant
* Adults must be able to provide informed consent
* Minors must have a parent or guardian able to provide informed consent
* Subjects must be 3-99 years of age
EXCLUSION CRITERIA:
* Persons with sensorineural hearing loss (SNHL) and/or peripheral vestibular dysfunction associated with a non-genetic etiology such as infection, metabolic or immunologic disorders, or exposure to ototoxic agents such as cisplatin, or aminoglycoside antibiotics will not be included in this protocol.
* Persons with sensorineural hearing loss known to be associated with surgical intervention (e.g. acoustic neuroma removal, failed stapedectomy).
Prospective study subjects who are cognitively impaired and lack consent capacity, will not be enrolled. The pre-screening eligibility checklist, which will be used and documented for registration under this protocol, is provided in a separate document.
Picking one helps us show the most relevant trials first.
Your results are loading in the background — you can
change this any time from the results page.
Set your location to continue
Find My Trials uses your location to surface clinical trials near you.
Add your city or zip code to your profile and try again.